Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Director/PDMR Shareholding

4 Mar 2024 09:35

RNS Number : 4585F
Indivior PLC
04 March 2024
 

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

The relevant notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

The Company announces that it was notified on March 1, 2024, that the following Persons discharging managerial responsibilities ('PDMR') exercised an option over ordinary shares of $0.50 each in the Company ('Shares'). The number of shares exercised are outlined below.

Name

Date of Grant

Number of Shares

Exercise Priceper Share

Date of Exercise

Kathryn Hudson

December 4, 2020

1,875

£4.80

March 1, 2024

Hillel West

December 4, 2020

2,250

£4.80

March 1, 2024

Following the transactions, Kathryn Hudson retained her interest in the shares and holds a beneficial interest in 32,858 Shares. On March 1, 2024, Hillel West sold the shares resulting from the option exercise and holds a beneficial interest in 27,733 Shares.

Kathryn Hudson

Company Secretary

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Kathryn Hudson

2

 

Reason for the notification

 

a)

 

Position/status

  

PDMR - Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Indivior PLC

b)

 

LEI

 

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Exercise of a share option under the ShareSave Plan

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£4.80

1875

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

N/A

e)

 

Date of the transaction

March 1, 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Hillel West

2

 

Reason for the notification

 

a)

 

Position/status

  

PDMR - Chief Manufacturing and Supply Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Indivior PLC

b)

 

LEI

 

213800V3NCQTY7IED471

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of US$0.50

 

 

GB00BN4HT335

b)

 

Nature of the transaction

Exercise of a share option under the ShareSave Plan and sale of the resulting shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volumes(s)

1. £4.80

2,250

2. £17.61

2,250

d)

 

Aggregated information

 

- Aggregated volume

 

 - Price

 

N/A

e)

 

Date of the transaction

March 1, 2024

f)

 

Place of the transaction

 

1. Outside a trading venue

2. London Stock Exchange (XLON)

 

 

This notification is made in accordance with the requirements of the Market Abuse Regulation.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUCWWUPCUBC
Date   Source Headline
27th Jun 20222:55 pmRNSRetraction - Holdings in Company
24th Jun 202211:45 amRNSSettlement with Dr. Reddy’s Laboratories
24th Jun 202211:40 amRNSHolding(s) in Company
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 20222:00 pmRNSHolding(s) in Company
22nd Jun 20227:00 amRNSTransaction in Own Shares
21st Jun 20221:15 pmRNSHolding(s) in Company
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20221:18 pmRNSHolding(s) in Company
20th Jun 20227:00 amRNSTransaction in Own Shares
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSTransaction in Own Shares
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 20227:00 amRNSTransaction in Own Shares
13th Jun 20227:00 amRNSTransaction in Own Shares
10th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20227:00 amRNSTransaction in Own Shares
7th Jun 20227:00 amRNSTransaction in Own Shares
6th Jun 20227:00 amRNSTransaction in Own Shares
1st Jun 202212:53 pmRNSFirst patient enrolled in AEF0117 Phase 2b study
1st Jun 20227:30 amRNSTotal Voting Rights
1st Jun 20227:00 amRNSTransaction in Own Shares
31st May 20227:00 amRNSTransaction in Own Shares
30th May 20227:00 amRNSTransaction in Own Shares
27th May 20227:00 amRNSTransaction in Own Shares
26th May 20227:00 amRNSTransaction in Own Shares
25th May 20227:00 amRNSTransaction in Own Shares
24th May 20229:00 amRNSIndivior to Participate in Conference
24th May 20227:00 amRNSTransaction in Own Shares
23rd May 202210:22 amRNSHolding(s) in Company
23rd May 20227:00 amRNSTransaction in Own Shares
20th May 20227:00 amRNSTransaction in Own Shares
19th May 20227:00 amRNSTransaction in Own Shares
18th May 202210:08 amRNSDirector Declaration
18th May 20227:00 amRNSTransaction in Own Shares
17th May 202212:32 pmRNSHolding(s) in Company
17th May 20227:00 amRNSTransaction in Own Shares
16th May 20227:00 amRNSTransaction in Own Shares
13th May 20227:00 amRNSTransaction in Own Shares
12th May 20227:00 amRNSTransaction in Own Shares
11th May 20227:00 amRNSTransaction in Own Shares
10th May 202210:59 amRNSBlock listing Interim Review
10th May 20227:00 amRNSTransaction in Own Shares
9th May 20227:00 amRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20222:55 pmRNSResult of AGM
5th May 20227:00 amRNSTransaction in Own Shares
4th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.